Edition:
United States

Foamix Pharmaceuticals Ltd (FOMX.A)

FOMX.A on American Stock Exchange

2.54USD
21 May 2019
Change (% chg)

-- (--)
Prev Close
$2.54
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
647
52-wk High
$6.55
52-wk Low
$2.41

About

Foamix Pharmaceuticals Ltd. is a clinical-stage pharmaceutical company. The Company is engaged in the development and commercialization of foam-based formulations, using its technology, which includes its foam platforms. It is focused on developing and commercializing its minocycline foam for the treatment of acne, rosacea and... (more)

Overall

Beta: 1.68
Market Cap(Mil.): $145.32
Shares Outstanding(Mil.): 54.43
Dividend: --
Yield (%): --

Financials

  FOMX.A Industry Sector
P/E (TTM): -- 93.91 35.38
EPS (TTM): -1.38 -- --
ROI: -100.81 7.62 11.72
ROE: -103.63 8.12 16.38

Earnings vs. Estimates